Suppr超能文献

黏液性水肿昏迷并发心源性休克的ST段抬高型心肌梗死的罕见表现:一例报告

An Unusual Presentation of ST Elevation Myocardial Infarction Complicated with Cardiogenic Shock Due to Myxedema Coma: A Case Report.

作者信息

Braiteh Nabil, Senyondo Godson D, Rahman Mohammed Faraaz, Chaudhry Raheel, Kashou Hisham

机构信息

Department of Cardiology, United Health Services Hospitals, Wilson Regional Medical Center, Johnson City, NY, USA.

Department of Internal Medicine, United Health Services Hospitals, Wilson Regional Medical Center, Johnson City, NY, USA.

出版信息

Am J Case Rep. 2021 Mar 10;22:e929573. doi: 10.12659/AJCR.929573.

Abstract

BACKGROUND Myxedema coma is an endocrine emergency with a high mortality rate, defined as a severe hypothyroidism leading to hypotension, bradycardia, decreased mental status, hyponatremia, hypoglycemia, and cardiogenic shock. Although hypothyroidism and cardiac disease has been interlinked, ST elevation myocardial infarction in the setting of myxedema coma have not been reported previously. CASE REPORT We report the case of a 70-year-old man who presented to the Emergency Department with chest pain and confusion. He also reported fatigue for the past week, which was progressively worsening. His past medical history was significant for renal cell carcinoma with metastatic bone disease being treated with chemotherapy (axitinib and pembrolizumab). In the Emergency Department, an ECG revealed inferior ST elevations. Shortly after presentation, the patient's blood pressure was decreasing, he became bradycardic (sinus), and his mental status was getting worse, so he was intubated for airway protection and was taken emergently for a cardiac catheterization, which failed to reveal an acute coronary occlusion. TSH was 60.6 mIU/L (0.465-4.680) mIU/ML, and free T4 0.3 ng/dL (0.8-2.2) ng/dL. The cardiac index was calculated to be 0.8 L/min/m² (normal range 2.6-4.2 L/min/m²), which confirmed cardiogenic shock due to myxedema coma. He was treated with levothyroxine (T4), liothyronine (T3), hydrocortisone, and multiple vasopressors but failed to respond and died 13 h after admission to the hospital. CONCLUSIONS Because of its rarity and high mortality, early diagnosis of myxedema coma and initiation of treatment by cardiologists requires a high level of suspicion, especially when patients with a history of hypothyroidism present with a cardiac complaint (ie, acute coronary syndrome, or bradycardia) that does not completely fit the clinical picture. It is of utmost importance for physicians to keep a wide differential diagnosis of other causes of ST elevation and/or persistent cardiogenic shock.

摘要

背景

黏液性水肿昏迷是一种死亡率很高的内分泌急症,定义为严重甲状腺功能减退导致低血压、心动过缓、精神状态改变、低钠血症、低血糖和心源性休克。虽然甲状腺功能减退与心脏疾病之间存在关联,但黏液性水肿昏迷患者发生ST段抬高型心肌梗死此前尚未见报道。病例报告:我们报告一例70岁男性患者,因胸痛和意识模糊就诊于急诊科。他还自述过去一周感到疲劳,且症状逐渐加重。他既往有肾细胞癌伴骨转移病史,正在接受化疗(阿昔替尼和派姆单抗)。在急诊科,心电图显示下壁ST段抬高。就诊后不久,患者血压下降,出现窦性心动过缓,精神状态恶化,因此为保护气道进行了气管插管,并紧急进行了心脏导管检查,但未发现急性冠状动脉闭塞。促甲状腺激素(TSH)为60.6 mIU/L(正常范围0.465 - 4.680 mIU/ML),游离甲状腺素(FT4)为0.3 ng/dL(正常范围0.8 - 2.2 ng/dL)。计算得出心脏指数为0.8 L/min/m²(正常范围2.6 - 4.2 L/min/m²),证实为黏液性水肿昏迷所致的心源性休克。给予左甲状腺素(T4)、碘塞罗宁(T3)、氢化可的松及多种血管升压药治疗,但患者无反应,入院13小时后死亡。结论:由于黏液性水肿昏迷罕见且死亡率高,心脏病专家要早期诊断并开始治疗,需要高度怀疑,尤其是当有甲状腺功能减退病史的患者出现不完全符合临床表现的心脏症状(如急性冠状动脉综合征或心动过缓)时。医生对ST段抬高和/或持续性心源性休克的其他病因进行广泛鉴别诊断至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a204/7957331/88efb43f80d7/amjcaserep-22-e929573-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验